We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Tecan’s Infinite® M1000 and a Plate of Live Fish!

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Tecan’s Infinite® M1000 and a Plate of Live Fish!"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Dr Jeff Mumm, Assistant Professor at GHSU, explained: “Quantitative microplate reader systems have revolutionized the pace of drug discovery, enabling the development of reporter¬-based in vitro and in silico assays that allow high throughput screening (HTS). However, biological validation has become a bottleneck in the drug discovery process, due to a lack of HTS-compatible in vivo assay platforms. Quantifying reporter levels in living zebrafish provides a versatile means of alleviating this road block.”

“The flexibility of the Infinite M1000 has allowed us to develop a simple and cost-effective automated screening method based on fluorescent or luminescent reporter detection in live zebrafish. Using this method we have been able to quantify the loss and regeneration of targeted cells in zebrafish disease models, as well as small molecule-induced changes in disease-linked molecular signaling pathways. High signal to noise ratios allow us to monitor changes in individual fish – which accounts for wide reporter level variance across populations by normalizing signals to each individual’s ground state – enabling us to detect long-term changes over several days. This powerful technique will benefit a wide variety of high throughput chemical and genetic screens in live zebrafish, potentially accelerating the validation of new drugs.”